Description

• Description of ESOROK Capsules

  Esorok 40mg is a proton pump inhibitor (PPI) that specifically inhibits the proton pump of the gastric parietal cell, the final stage of gastric acid secretion. It is administered as a prodrug, activated by sulfitase, an enzyme present in the gut, which transforms esorok into its active form. This activation increases the drug’s lipophilicity, allowing it to cross the cell membrane and bind to the proton pump. Esorok 40mg cap is a potent and efficient inhibitor of the gastric proton pump, H+/K+ ATPase, which leads to a decrease in gastric acidity and increased pH levels. Esorok is indicated for the treatment of symptoms associated with gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, treatment of gastric ulcers, in combination with other treatments, Helicobacter pylori infection, and the management of Zollinger-Ellison syndrome. Although PPIs are commonly used to reduce stomach acid, they should be prescribed and administered with caution. Always consult a healthcare professional for medical advice and proper medication usage.

• Ingredients of ESOROK Capsules

  Esomeprazole

• Drug Class of ESOROK Capsules

  Proton Pump Inhibitors (PPI’s)

• Dosage Form of ESOROK Capsules

  Capsule

• Uses of ESOROK 40mg Capsule

  Unveiling its multifaceted uses and transformative applications as follows:

  • Treats symptoms of gastroesophageal reflux disease (GERD) and other stomach related issues
  • Healing of erosive esophagitis (damage to the esophagus from stomach acid)
  • Helps prevent recurrence of stomach ulcers caused by NSAIDs (non-steroidal anti-inflammatory drugs)
  • Treatment of Zollinger-Ellison syndrome (a condition where the stomach produces too much acid)
  • Can be used in combination with antibiotics (e.g. amoxicillin and clarithromycin) for the treatment of H. pylori infection which can cause ulcers

• Dosage of Esorok

  Tailoring Treatment for Optimal Health, Prescribed Medication Dosage is:

  • Heartburn and gastroesophageal reflux disease (GERD)- Dosage – 20-40 mg once daily for 4-8 weeks, Duration – 4-8 weeks
  • Duodenal Ulcer- Dosage – 40 mg once daily for 4 weeks, or 8 weeks if the ulcer has lasted for over a year, Duration – 4 weeks
  • Stomach Ulcer- Dosage • 8 weeks, or 12 weeks if associated with NSAID or COX-2 inhibitor, Duration – 8 weeks
  • Zollinger-Ellison Syndrome- Initial Dosage – 60 mg once daily, Recommended Increases – May be increased to 120 mg once daily if needed